V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009234 | 260006014 | 1.86 | null | null | null | 2015-04-02 | Rituximab | null | null | 260029477 | RITUXIMAB |
| 260009235 | 260006015 | 1.82 | 57.6 | Palliative (P) | null | 2017-01-29 | ESHAP | N | N | 260029480 | CISPLATIN + ETOPOSIDE |
| 260009236 | 260006016 | 1.66 | 58.2 | Curative (C) | 2016-08-04 | 2016-08-04 | PACIFICO TRIAL | 02 | N | 260029482 | CHLORAMBUCIL + RITUXIMAB |
| 260009237 | 260006016 | null | 63 | Palliative (P) | null | 2013-05-28 | PACIFICO TRIAL | null | null | 260029482 | CAPECITABINE |
| 260009238 | 260006017 | 1.79 | 82 | Curative (C) | 2017-03-05 | 2017-03-09 | Rituximab | 2 | N | 260029485 | TRIAL |
| 260009239 | 260006018 | 1.71 | 74 | Curative (C) | 2019-02-10 | 2019-02-17 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260029486 | CHLORAMBUCIL |
| 260009240 | 260006019 | 1.6 | 76.4 | Curative (C) | 2018-03-06 | 2018-03-07 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260029487 | RITUXIMAB |
| 260009241 | 260006020 | 1.7 | 77 | Curative (C) | 2018-05-16 | 2018-05-18 | Rituximab | N | N | 260029492 | ENZALUTAMIDE |
| 260009242 | 260006021 | 1.65 | 98.8 | null | 2016-03-19 | 2016-04-03 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260029498 | CYCLOPHOSPHAMIDE |
| 260009243 | 260012194 | 1.52 | 66.5 | Curative (C) | 2016-02-04 | 2016-02-08 | Rituximab | N | N | 260029500 | CISPLATIN |
| 260009244 | 260006022 | 1.78 | 70.6 | Curative (C) | 2015-08-24 | 2016-03-23 | CISPLATIN + ETOPOSIDE | N | N | 260029501 | TRIAL |
| 260009245 | 260006023 | 1.66 | 73.6 | null | 2016-11-07 | 2016-11-14 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 260029502 | RITUXIMAB |
| 260009247 | 260006024 | null | 69 | null | 2013-10-29 | 2013-10-29 | Chlorambucil | null | N | 260029505 | RITUXIMAB |
| 260009248 | 260006024 | 1.88 | null | Neo-adjuvant (N) | 2015-01-19 | 2015-01-19 | Rituximab (Maintenance) | 01 | N | 260029505 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260009249 | 260006025 | null | 74 | Curative (C) | 2018-11-10 | 2018-11-12 | Rituximab | 02 | N | 260029508 | CHOP |
| 260009250 | 260006026 | 1.77 | 73 | Curative (C) | 2014-05-24 | 2014-06-01 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | 260029509 | RITUXIMAB |
| 260009251 | 260006026 | 1.72 | 109.7 | Adjuvant (A) | 2013-09-20 | 2013-09-20 | Cisplatin + Etoposide (5 day) | N | N | 260029509 | PEMBROLIZUMAB |
| 260009252 | 260006027 | 1.58 | null | Palliative (P) | 2015-02-21 | 2015-03-05 | Azacitidine | N | N | 260029511 | RITUXIMAB |
| 260009253 | 260006027 | null | 82 | Curative (C) | 2017-10-29 | 2017-10-30 | Obinutuzumab + CVP | N | N | 260029511 | CARBOPLATIN + ETOPOSIDE |
| 260009254 | 260006028 | 1.79 | 81.7 | Palliative (P) | 2016-09-12 | 2016-09-29 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260029513 | RITUXIMAB |
| 260009255 | 260006028 | 1.79 | 76 | null | 2014-03-06 | 2014-03-27 | Oxaliplatin + Modified de Gramont | N | N | 260029513 | HYDROXYCARBAMIDE |
| 260009256 | 260006029 | 1.71 | null | Disease modification (D) | 2014-03-12 | 2014-03-15 | Nilotinib | 1 | N | 260029515 | DABRAFENIB |
| 260009257 | 260006029 | 1.81 | 134 | null | 2015-08-21 | 2015-08-31 | Rituximab (Maintenance) | 2 | null | 260029515 | RITUXIMAB |
| 260009258 | 260006029 | 1.58 | 52 | null | null | 2015-01-15 | CARBOPLATIN + PACLITAXEL | null | null | 260029515 | RITUXIMAB |
| 260009259 | 260006030 | 1.75 | null | null | 2014-08-26 | 2014-08-26 | null | 01 | null | 260029520 | ESHAP R |
| 260009260 | 260006030 | 1.85 | null | Curative (C) | 2013-10-09 | 2016-03-26 | Rituximab | N | N | 260029520 | RITUXIMAB |
| 260009261 | 260006030 | 1.7 | 78 | Palliative (P) | 2014-12-12 | 2014-12-12 | Rituximab | 02 | N | 260029520 | RITUXIMAB |
| 260009262 | 260006031 | 1.69 | 101.8 | Curative (C) | 2015-10-26 | 2015-11-09 | BENDAMUSTINE | N | N | 260029525 | OFATUMUMAB |
| 260009263 | 260006031 | 1.81 | 71.6 | Palliative (P) | 2015-03-22 | 2015-04-12 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 2 | N | 260029525 | CARBOPLATIN + ETOPOSIDE |
| 260009264 | 260006032 | 1.69 | 77.1 | Curative (C) | 2018-04-27 | 2018-05-04 | CISPLATIN + ETOPOSIDE | 2 | Y | 260029529 | DOCETAXEL |
| 260009265 | 260012203 | 1.8 | null | Palliative (P) | 2016-02-25 | 2016-02-25 | ESPAC-4 TRIAL | 01 | N | 260029530 | VINCRISTINE |
| 260009266 | 260012203 | null | null | Palliative (P) | 2016-06-18 | 2016-06-19 | Rituximab | N | N | 260029530 | ESHAP R |
| 260009267 | 260006033 | 1.67 | null | Palliative (P) | 2019-02-19 | 2019-02-19 | EP | 2 | N | 260029532 | CISPLATIN + VINORELBINE |
| 260009268 | 260006034 | 1.8 | 87 | null | null | 2015-04-07 | CAPECITABINE + RT | null | null | 260029534 | RITUXIMAB |
| 260009269 | 260006034 | 0 | 71.2 | Palliative (P) | 2015-11-07 | 2015-11-29 | Capecitabine 35days + RT | N | N | 260029534 | RITUXIMAB |
| 260009270 | 260015624 | 1.79 | 70.6 | Curative (C) | 2017-08-05 | 2017-08-30 | Rituximab | N | N | 260029536 | RITUXIMAB |
| 260009271 | 260015624 | 1.77 | 83.5 | Not known (9) | 2014-01-29 | 2014-01-30 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | 260029536 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260009272 | 260006035 | 1.77 | 67.3 | Curative (C) | 2016-09-19 | 2016-09-19 | CHOP - 21 days | 2 | N | 260029540 | RITUXIMAB |
| 260009273 | 260006035 | null | 61.7 | Disease modification (D) | 2014-04-07 | 2014-04-21 | CYCLOPHOSPHAMIDE | N | N | 260029540 | CISPLATIN |
| 260009274 | 260006035 | 1.74 | 83.2 | Curative (C) | null | 2014-04-27 | Rituximab | null | null | 260029540 | CHOP |
| 260009275 | 260006035 | 1.53 | 64.3 | Not known (9) | 2014-08-31 | 2014-09-01 | R-EPOCH | Y | N | 260029540 | RITUXIMAB |
| 260009276 | 260018385 | 1.64 | 107.4 | Disease modification (D) | 2017-04-05 | 2017-04-06 | Rituximab | N | N | 260029551 | CHLORAMBUCIL + RITUXIMAB |
| 260009277 | 260018385 | 1.63 | 101.6 | Disease modification (D) | 2014-12-22 | 2015-06-22 | Carboplatin + Pemetrexed | N | N | 260029551 | CARBOPLATIN + ETOPOSIDE |
| 260009278 | 260006036 | 1.63 | null | Curative (C) | 2016-08-14 | 2016-08-15 | Chlorambucil | 02 | N | 260029555 | RITUXIMAB |
| 260009279 | 260012206 | null | 60 | Neo-adjuvant (N) | 2015-01-07 | 2015-01-18 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 260029557 | CHLORAMBUCIL |
| 260009280 | 260006037 | 1.59 | 75 | Adjuvant (A) | 2017-03-03 | 2017-03-05 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 260029558 | RITUXIMAB |
| 260009281 | 260006037 | 1.57 | 48 | Not known (9) | 2018-07-31 | 2018-08-20 | Rituximab | Y | N | 260029558 | RITUXIMAB |
| 260009282 | 260006037 | null | 62 | null | 2015-01-31 | 2015-02-01 | Rituximab | null | N | 260029558 | RITUXIMAB |
| 260009283 | 260006038 | null | 79 | Not known (9) | 2015-03-23 | 2015-04-04 | Bendamustine +/- Prednisolone | N | N | 260029565 | RITUXIMAB |
| 260009284 | 260012208 | 1.8 | null | Curative (C) | 2016-07-31 | 2016-08-03 | Fluorouracil + Folinic Acid Weekly | N | N | 260029566 | MITOMYCIN INTRAVESICULAR |